Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-07

Clinical Trial Update: Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial investigating radical surgery with or without adjuvant radiotherapy for intermediate-risk cervical cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Central and Eastern European Gynecologic Oncology Group | Conditions: Cervical Cancer | Phase 3 | Status: RECRUITING